CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31

Core Laboratories Inc. /DE/

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$10.15+0.15 (+1.50%)

Close on Oct 19, 2026

Market cap: $475.81M
P/E (TTM): 19.5
Dividend yield: 0.39%

Core Laboratories Inc. /DE/ income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	527	524	510	490	470
Cost of Revenue	418	421	400	394	–
Gross Profit	109	103	110	96	–
General & Administrative	45	40	40	38	–
Operating Income	56	59	55	42	45
Interest Expense	11	12	13	12	9.15
Income from Equity Investments	46	46	41	30	36
Other Non-Operating Income	7.61	9.95	0.85	0.72	-5.60
Asset Impairment Charges	0.03	1.11	1.14	0	0
Gain (Loss) on Sale of Assets	0.81	1.78	0.20	1.07	0.43
Pretax Income	46	46	41	30	36
Income Tax Expense	16	14	4.19	10	16
Net Income incl. Noncontrolling Interests	30	32	37	20	20
Minority Interest in Earnings	0.72	0.75	0.35	0.21	0.49
Net Income	30	31	37	19	20
EPS (Basic)(per share)	0.64	0.67	0.79	0.42	0.43
EPS (Diluted)(per share)	0.63	0.66	0.77	0.42	0.42
Shares Outstanding (Basic, Weighted)(shares)	46	47	47	46	46
Shares Outstanding (Diluted, Weighted)(shares)	47	48	48	47	47
Dividend per Share(per share)	0.04	0.04	0.04	0.04	0.04
EBITDA	71	74	70	59	64

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 19.5%
Operating margin: 9.2%
Net margin: 4.7%
Return on equity, FY2025: 11.6%

Financial strength

Current ratio: 2.12
Debt to equity: 0.42
Debt to assets: 19.4%
Cash to current liabilities: 22.5%

Valuation

P/E ratio: 19.5
Price to sales: 0.92
Price to book: 1.75
Dividend yield: 0.39%